optimization of standard aml treatment: apl advances, adverse cytogenetics & post-remission therapy
Published 6 years ago • 333 plays • Length 11:35Download video MP4
Download video MP3
Similar videos
-
2:09
advances in the management of fit adults with aml
-
7:52
advances in aml understanding: apl therapy, immunotherapy and maintenance therapy
-
3:47
the impact of cytogenetic-risk stratification on aml outcomes
-
1:59
optimizing the use of flt3 inhibitors in aml: sequencing, post-transplant maintenance & more
-
2:34
the evolution of the aml treatment paradigm
-
3:37
the future of aml treatment
-
2:03
maintenance therapy in aml
-
2:25
optimizing haplo-sct for the treatment of aml
-
0:57
potential approval of quizartinib in aml & its place in the aml treatment regimen
-
3:14
determining the optimal frontline treatment of aml
-
3:16
the optimization of induction chemotherapy for patients with aml
-
2:58
evolution of the aml treatment paradigm
-
8:21
quazar aml-001: a new standard for aml maintenance therapy
-
1:38
cytogenetic risk stratification in flt3-mt npm1-negative aml undergoing allosct in remission
-
1:39
optimizing chemotherapy in aml
-
3:26
major aml treatment landscape changes
-
5:11
the frontline treatment strategy for newly diagnosed aml
-
1:41
the importance of integrating genomic and cytogenetic data in treatment decisions for aml
-
1:21
intensive therapy of older aml